- 3-2-1 Health Tech
- Posts
- 3-2-1 Autoimmune Disorders
3-2-1 Autoimmune Disorders
Priyanka Vaidya
March 10, 2025
Autoimmune disorders are conditions in which the immune system mistakenly attacks healthy tissues instead of defending against harmful invaders like bacteria and viruses. This misdirected immune response can lead to inflammation, tissue damage, and changes in organ function. There are over 80 known autoimmune diseases, which can be categorized as organ-specific (affecting one organ) or non-organ-specific (impacting multiple systems). Examples include rheumatoid arthritis, type 1 diabetes, lupus, and multiple sclerosis.
Globally, autoimmune disorders are estimated to affect 5-10% of the population in industrialized regions, with prevalence increasing over time. The increase is due to factors such as improved diagnosis, environmental changes, and genetic predispositions, with women being disproportionately impacted.
3 startups making an impact in this space:
Company | |||
Location | Israel | US | US |
Modality | Diagnosis | Therapeutics | Therapeutics |
Descriptor | First deep learning-based solution for early detection and intervention selection of autoimmune diseases. | A clinical-stage biotech company working to develop first-in-class therapies designed to reprogram the immune system, induce tolerance to specific antigens, and preserve immune functionality. | Personalized, multidimensional autoimmune care leveraging lifestyle and nutrition coaching. |
Core Problem | Diagnosing and treating autoimmune disorders is a complex and time-consuming problem. Since the disease involves multiple systems and has many common non-specific consuming symptoms, the patient has to undergo numerous procedures and tests delaying intervention. | Traditional biologic solutions have serious side effects, including increased risk of infections due to immunosuppression or a new autoimmune condition triggered by the drug. | Diagnosing an autoimmune disease can take a long time because there is no single test, and the disease can relapse and remit by itself. Autoimmune diseases disproportionately affect women, and unfortunately, healthcare delivery models do not take into account the impact of gender on various diseases. |
Solution | Predicta Med streamlines the diagnostic process by aggregating EMR and claims data and further enriching this data with self-supervised learning and natural language processing to discover patients at risk of having an autoimmune disease. | COUR’s platform of immune-modifying nanoparticles aims to treat the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression. | WellTheory is a collaborative care model that integrates with patients’ existing physicians and specialists and offers holistic support in between medical visits. This multimodal approach offers 1:1 telehealth sessions, unlimited messaging with health coaches, and at-home kits to identify the root cause contributing to the patient’s symptoms. Well Theory’s women’s health program addresses the link between autoimmune diseases and hormone imbalance. |
Product Suite | A stand-alone primary care software that is available as a cloud or on-premise solution. An integration suite that combines EMR and care manager software. | Pipelines in various development phases include solutions for: T1 Diabetes Myasthenia Gravis Celiac Disease Primary biliary cholangitis | A D2C membership model that offers personalized holistic care plans and telehealth support. A B2B model that offers health payors and employers cost reduction options by driving down speciality drug costs, fewer ER/Urgent care visits and improvement in symptoms. |
Regulatory Status | Currently not FDA-approved as a medical device. | Recently received FDA clearance for its investigational new drug application for a nanoparticle developed to address the underlying autoimmunity of Type 1 diabetes (T1D). | Not applicable, as this is a low-risk product that promotes a healthy lifestyle. |
Funding Stage | Seed | Series A | Seed |
Team | Founded by engineers with a strong track record in medical devices and machine learning. | Strong team with expertise in clinical development, scientific research, manufacturing, and business. | The founder witnessed the healthcare system’s shortcomings while navigating her autoimmune journey. |
Traction | Strong traction, including partnerships with Cedars-Sinai and Mayo Clinic and funding from Google for startups. | Strong traction with Takeda and Genentech partnerships in place. | Strong D2C model with growth picking up in the B2B space, including adoption by Maven Clinic. |
2 actionable insights to inspire your strategy.
Nanotechnology Nanotechnology offers innovative strategies for combating autoimmune disorders by precisely targeting immune responses and reducing systemic side effects. Key approaches include: Targeted delivery of therapeutics where nanoparticles encapsulate drugs or biologics to induce anti-inflammatory states, minimizing damage to healthy tissues and enhancing drug efficacy. Inducing immune tolerance by engineering nanoparticles to deliver autoantigens directly to the antigen-presenting cells. Injecting nanovaccines, which are a novel approach leveraging nanomaterials to cause long-lasting immune tolerance. | AI/ML Artificial intelligence (AI) and machine learning (ML) are revolutionizing the prediction, detection, diagnosis, and treatment of autoimmune disorders. Here are the key trends: Advanced AI algorithms are being developed to analyze genetic data and identify risk factors for autoimmune diseases. AI-based tools like the Genetic Progression Score (GPS) predict the progression of autoimmune diseases from preclinical stages using genetic data and electronic health records. ML models analyze multimodal data from electronic health records, while AI enhances the personalization of therapeutic strategies by identifying patients most likely to benefit from specific treatments based on their genetic profiles and disease progression patterns. |
1 key resource to deepen your understanding.
Is it possible to combat Autoimmune Disorders by editing our genes?! Find out in this wonderful episode at Medical Minds.
And that’s all for today. See you next Monday!
Would love to hear your feedback. If you like the newsletter, please share it with your friends and colleagues!